Akums Drugs and Pharmaceuticals Limited (BOM:544222)

Market Cap	81.95B +1.1%
Revenue (ttm)	43.59B +5.8%
Net Income	2.55B -24.5%
EPS	16.67 -26.3%
Shares Out	n/a
PE Ratio	32.11
Forward PE	22.48
Dividend	n/a
Ex-Dividend Date	n/a

Volume	10,329
Open	533.25
Previous Close	532.90
Day's Range	533.25 - 548.15
52-Week Range	410.10 - 620.00
Beta	n/a
Analysts	Strong Buy
Price Target	673.33 (+25.7%)
Earnings Date	May 14, 2026

About BOM:544222

Akums Drugs and Pharmaceuticals Limited manufactures and sells pharmaceutical products and active pharmaceutical ingredients India and internationally. The company provides drugs, ayurvedic, herbals, toiletries, nutraceuticals, food and dietary supplements, derma and cosmetics, healthcare and hospital products, over-the-counter (OTC) products, active pharmaceutical ingredients, excipients, and compounds. It also offers branded formulations on various dosage forms, including tablets, capsules, injectables, opthalmics, and soft gelatin capsules f...

• Industry: Pharmaceutical Preparations
• Founded: 2004
• Employees: 7,536
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 544222

Financial Performance

In fiscal year 2026, BOM:544222's revenue was 43.59 billion, an increase of 5.77% compared to the previous year's 41.21 billion. Earnings were 2.55 billion, a decrease of -24.54%.